Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Emcure doubling down on biosimilars pipeline: MD Satish Mehta
Emcure currently has six biosimilars in the market, launched through its subsidiary Gennova Biopharmaceuticals. While it has developed these in-house so far, the drugmaker will also scout for partners with products not in their pipeline, for commercialisation in India as well as emerging markets.
Emcure Pharmaceuticals consolidated net profit rises 28.81% in the March 2026 quarter
Sales rise 16.70% to Rs 2469.70 crore
Emcure Pharma Q4 Results: Stock slips from 52-week high despite revenue, margin growth
Emcure Pharma posts 29% profit growth and 17% revenue rise in Q4FY26; stock falls over 5% after hitting a 52-week high of ₹1,830, despite strong international business momentum and margin gains.
Stock Alert: Wockhardt, Jindal Stainless, Petronet LNG, Manappuram Finance, Aarti Industries
Larsen & Toubro, Mahindra and Mahindra, Punjab National Bank, Marico, Hero Motocorp, Lloyds Metals and Energy, SRF, Coforge, United Breweries, Poonawalla Fincorp, Ajanta Pharma, Emcure Pharmaceuticals, Aadhar Housing Finance, Gallantt Ispat, Jammu and Kashmir Bank, Voltamp Transformers, AAVAS Financiers, Lloyds Engineering Works, Alkyl Amines Chemicals, SJS Enterprises, Shilchar Technologies, GNG Electronics, Gujarat Heavy Chemicals, Aeroflex Industries, Shanthi Gears, Shoppers Stop, Dalmia Bharat Sugar and Industries, Cigniti Technologies, Raymond Realty, Raymond, Shipping Corporation of India Land and Assets, PTC India Financial Services, Spandana Sphoorty Financial, Dolphin Offshore Enterprises (India), CFF Fluid Control, DCW, Automobile Corporation of Goa (ACGL), Paushak, Mafatlal Industries, B Right Realestate, Kothari Petrochem, Foseco Crucible (India), Sutlej Textiles and Industries, Primo Chemicals, Onward Technologies, Kriti Nutrients, Jenburkt Pharma, Kriti Industries ..
Q4 Results Today: Coforge, Larsen And Toubro, Raymond, Emcure Pharma, Mahindra And Mahindra Among 60+ Companies To Declare Earnings
United Breweries, Raymond Realty, Shoppers Stop and Punjab National Bank are among the companies slated to declare earnings on May 5.
Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirer
Emcure Pharmaceuticals saw a significant block deal where BC Investments IV Limited sold 18 lakh shares for Rs 289 crore to Norges Bank. The pharma company, which manufactures APIs and formulations, has shown strong performance with a 67% return in the past 12 months and a 50% YoY growth in net profit.
These seven stocks gained up to nearly 14% to hit fresh record highs today
Emcure Pharma, Tenneco Clean Air, Emmvee Photovoltaic, GE Sipping, Welspun Corp, Bharat Forge and MCX are the stocks that hit fresh record highs in trade on Wednesday, April 29. The stocks have gained in the 2.9% to 13.7% range.
Emcure Pharma cuts Poviztra starting dose price by 55% to boost patient access
Emcure cuts Poviztra starting dose price by 55% to 3999 rupees a month from April 2026 to boost obesity care access, shares fall 2.39% on NSE
Stock market today: Trade setup for Nifty 50, US-Iran war, crude oil, gold, silver rates — 8 stocks to buy or sell
Stock market today: Market analysts recommend eight stocks for intraday trading, including Can Fin Homes and Emcure Pharmaceuticals, citing technical analysis and market conditions. Investors are advised to monitor geopolitical developments and market volatility closely for potential opportunities.
Emcure Pharmaceuticals soars 9% in weak market on huge volumes
Emcure Pharmaceuticals stock was quoting close to its 52-week high of ₹1,585.50 on Monday, and has surged up to 62% in the last one year.
Emcure partners Roche to distribute kidney transplant and anemia therapies in India
Emcure Pharmaceuticals signs a distribution deal with Roche to supply CellCept, Mircera, and Neorecormon for nephrology and transplant care in India, effective April 1, 2026.
Emcure Pharmaceuticals signs distribution agreement with Roche
For Roche's select brands in nephrology and transplant segment in India